| Title : The dipeptidyl peptidase-4 inhibitor linagliptin ameliorates LPS-induced acute lung injury by maintenance of pulmonary microvascular barrier via activating the Epac1\/AKT pathway - Zhang_2022_Biomed.Pharmacother_155_113704 |
| Author(s) : Zhang N , Tang S , Zhang J , Pei B , Pang T , Sun G |
| Ref : Biomed Pharmacother , 155 :113704 , 2022 |
| Abstract : Zhang_2022_Biomed.Pharmacother_155_113704 |
| ESTHER : Zhang_2022_Biomed.Pharmacother_155_113704 |
| PubMedSearch : Zhang_2022_Biomed.Pharmacother_155_113704 |
| PubMedID: 36115114 |
Zhang N, Tang S, Zhang J, Pei B, Pang T, Sun G (2022)
The dipeptidyl peptidase-4 inhibitor linagliptin ameliorates LPS-induced acute lung injury by maintenance of pulmonary microvascular barrier via activating the Epac1\/AKT pathway
Biomed Pharmacother
155 :113704
Zhang N, Tang S, Zhang J, Pei B, Pang T, Sun G (2022)
Biomed Pharmacother
155 :113704